癌症患者的姑息治疗:ASCO指南更新
ASCO召集多学科专家组,检索2015至2023年发表的系统综述、Meta分析和随机对照试验,共纳入52项相关研究,更新2016年ASCO指南,提出将姑息治疗整合入肿瘤标准治疗的循证推荐。推荐肿瘤科医生在疾病早期即将晚期实体瘤和血液系统恶性肿瘤患者转诊至专科跨学科姑息治疗团队,并关注患者照护者的支持需求。
要点
- 肿瘤科医生应在疾病早期将晚期实体瘤和血液系统恶性肿瘤患者转诊至提供门诊和住院治疗的专科跨学科姑息治疗团队,与积极抗肿瘤治疗同步进行。
- 对于存在未处理的身体、心理社会或灵性痛苦的癌症患者,癌症照护项目应提供专门的专科姑息治疗服务,补充现有或新出现的支持治疗干预。
- 跨学科癌症照护团队的肿瘤科医生可将癌症患者的照护者转诊至姑息治疗团队以获得额外支持;专家组建议早期参与姑息治疗,尤其对症状未控制和有生活质量担忧的患者。
核心结论
- 更新2016年ASCO指南,提供循证推荐以指导将姑息治疗整合入所有癌症患者的标准肿瘤治疗。
研究设计与样本
- ASCO召集医学、放疗、血液肿瘤、肿瘤护理、姑息治疗、社会工作、伦理、倡导和心理肿瘤学专家组成专家组。
- 专家组进行文献检索,纳入2015至2023年发表的系统综述、Meta分析和随机对照试验。
- 关注结局包括生活质量、患者满意度、躯体和心理症状、生存及照护者负担,专家组成员使用可用证据和非正式共识制定循证指南推荐。
- 文献检索识别出52项相关研究作为本指南的证据基础。
主要发现
- 文献检索识别出52项相关研究用于构建本指南的证据基础。
关键数值与推荐
- 肿瘤科医生应将晚期实体瘤和血液系统恶性肿瘤患者转诊至提供门诊和住院治疗的专科跨学科姑息治疗团队,从疾病早期开始,与癌症积极治疗同步进行。
- 对于存在未处理的身体、心理社会或灵性痛苦的癌症患者,癌症照护项目应提供专门的专科姑息治疗服务,补充现有或新出现的支持治疗干预。
- 跨学科癌症照护团队的肿瘤科医生可将癌症患者的照护者(如家人、自选家人和朋友)转诊至姑息治疗团队以获得额外支持。
- 专家组建议早期参与姑息治疗,尤其对症状未控制和有生活质量担忧的患者。
- 照护正在接受I期临床试验的实体瘤患者的临床医生也可将其转诊至专科姑息治疗。
临床怎么用
- 肿瘤科医生应在疾病早期将晚期实体瘤和血液系统恶性肿瘤患者转诊至专科跨学科姑息治疗团队,与积极抗肿瘤治疗同步进行。
- 癌症照护项目应为存在未处理的身体、心理社会或灵性痛苦的患者提供专门的专科姑息治疗服务,补充现有或新出现的支持治疗干预。
- 跨学科癌症照护团队的肿瘤科医生可将癌症患者的照护者转诊至姑息治疗团队以获得额外支持。
- 专家组建议早期参与姑息治疗,尤其对症状未控制和有生活质量担忧的患者。
- 照护正在接受I期临床试验的实体瘤患者的临床医生也可将其转诊至专科姑息治疗。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To provide evidence-based guidance to oncology clinicians, patients, nonprofessional caregivers, and palliative care clinicians to update the 2016 ASCO guideline on the integration of palliative care into standard oncology for all patients diagnosed with cancer. METHODS: ASCO convened an Expert Panel of medical, radiation, hematology-oncology, oncology nursing, palliative care, social work, ethics, advocacy, and psycho-oncology experts. The Panel conducted a literature search, including systematic reviews, meta-analyses, and randomized controlled trials published from 2015-2023. Outcomes of interest included quality of life (QOL), patient satisfaction, physical and psychological symptoms, survival, and caregiver burden. Expert Panel members used available evidence and informal consensus to develop evidence-based guideline recommendations. RESULTS: The literature search identified 52 relevant studies to inform the evidence base for this guideline. RECOMMENDATIONS: Evidence-based recommendations address the integration of palliative care in oncology. Oncology clinicians should refer patients with advanced solid tumors and hematologic malignancies to specialized interdisciplinary palliative care teams that provide outpatient and inpatient care beginning early in the course of the disease, alongside active treatment of their cancer. For patients with cancer with unaddressed physical, psychosocial, or spiritual distress, cancer care programs should provide dedicated specialist palliative care services complementing existing or emerging supportive care interventions. Oncology clinicians from across the interdisciplinary cancer care team may refer the caregivers (eg, family, chosen family, and friends) of patients with cancer to palliative care teams for additional support. The Expert Panel suggests early palliative care involvement, especially for patients with uncontrolled symptoms and QOL concerns. Clinicians caring for patients with solid tumors on phase I cancer trials may also refer them to specialist palliative care.Additional information is available at www.asco.org/supportive-care-guidelines.
引用
- Sanders JJ, Temin S, Ghoshal A, et al. Palliative Care for Patients With Cancer: ASCO Guideline Update. J Clin Oncol. 2024. PMID: 38748941. doi:10.1200/JCO.24.00542
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。